Dr. Gary E. Deng, MD

Dr. Deng practices at UCI Health - Orange in Orange, California, part of UC Irvine.

Dr. Deng's NPI, 1780655233, was assigned on January 31, 2006. Dr. Deng graduated from Beijing Medical University in 1987. Dr. Deng holds California license C198282.

Dr. Deng's primary practice is UCI Health - Orange, at 101 City Drive South, Orange, CA 92868 in Orange County. The practice phone is (714) 456-7890.

Dr. Deng's primary practice is UCI Health - Orange in Orange, California, part of UC Irvine. The medical group on file is UCI Health Physicians. Dmand AI also links Dr. Deng to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Deng practices, 2 sites in all. Vendor and product names are available with a free account.

Integrative medicine is Dr. Deng's primary specialty in the NPI Registry, under taxonomy code 202D00000X. Dr. Deng is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Deng's licenses on file in 9 states: California, Florida, New York, Connecticut, New Jersey, North Carolina, Colorado, Maryland and Hawaii.

Dmand AI lists gastroenteritis, insomnia and osteoporosis among the conditions Dr. Deng treats.

CMS data shows 295 Medicare services from Dr. Deng across 6 procedure codes in 2024, for 246 Medicare patients. Medicare paid $36,595 for them. Every service was in an office.

CMS counts 246 Medicare patients who saw Dr. Deng in 2024. The largest group is 65 to 74, with 137 patients. 68% of them have cancer, and 68% have high cholesterol. 11% are also on Medicaid. Their average risk score is 2.11, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Deng's median patient age at 60, with 72% women.

In 2024, Dr. Deng wrote 22 Medicare Part D claims. 100% of them were for generic drugs. CMS names the drug for 16 of them, across 1 drug with 11 or more claims each, at $175 in total drug cost. In 2016, CMS named 11 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 76 out of 100 for Dr. Deng for performance year 2024, reported as part of a group. Dr. Deng accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Deng as offering telehealth.

Dmand AI links 55 papers to Dr. Deng, published from 2005 to 2023. 2013 was the busiest year, with 3. The most frequent topics are Acupuncture Therapy, Complementary Therapies and Integrative Medicine. Dr. Deng has published most often in Integr Cancer Ther. Dr. Deng's most frequent co-authors are Jun J. Mao, MD, Sergio A. Giralt, MD and Dawn Lauryn Hershman, MD.

Dmand AI links Dr. Deng to 8 clinical trials, 3 of them phase 2 studies. 2 are still active or recruiting. Conditions studied include Postoperative Nausea and Vomiting, Vomiting and Agnosia. Memorial Sloan Kettering Cancer Center sponsors the most, 8.

CMS Open Payments shows 5 general payments to Dr. Deng from 4 drug and device companies from 2016 to 2017. Education speaker fees make up the largest share, 86% of the total. Helsinn Healthcare SA paid the most, $2,500.

Dr. Deng graduated from Beijing Medical University in 1987.

Dr. Deng is in network with 14 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.